Real-time enrollment status for this type 1 diabetes clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 12:08 PM UTC
| NCT Number | NCT06914895 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Type 1 Diabetes |
| Phase | Clinical Trial |
| Target Enrollment | 905 participants |
| Active Locations | 32 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | February 17, 2026 (1 week ago) |
As of March 2, 2026: Clinical trial NCT06914895 is currently active_not_recruiting participants. This clinical trial study for type 1 diabetes is not currently accepting new participants at 32 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06914895 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 32 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06914895 was last updated 1 week ago (February 17, 2026). HelloStudys verifies this status automatically.